Microbiological Profile of Post-COVID-19 Mucormycosis in Various Samples

• Published in: International journal of scientific research in dental and medical sciences (Online) Vol. 4; no. 2; pp. 87 - 91
• Main Authors: Sirisha Munipati, Hymavathi Rachamadugu, Surekha Avileli, Renuka Avula, Naga Beladona, Shanthi Boyapally
• Format: Journal Article
• Language: English
• Published: International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS) 01.06.2022
• Subjects: infections; mucor; rhizopus; sars-cov-2
• ISSN: 2676-5497; 2676-5373
• DOI: 10.30485/ijsrdms.2022.338567.1285

Background and aim: Increase in fungal superinfections among post-COVID-19 patients created a panic during pandemic times in India. Rhino-orbital mucormycosis cases have seen a rise in India among COVID-19 patients. This study aims and objectives to know the Incidence of Mucormycosis among COVID-19 infected patients and the age and sex distribution of Post COVID-19 Mucormycosis patients. Material and methods: All clinical specimens were received at the Microbiology department from respective hospital units in sterile normal saline leak-proof containers. Fungal cultures were followed until growth occurred or till 28 days. Macroscopic and microscopic characteristics identified positive culture fungal growth. Results: Out of 97 post covid fungal infection patients in this study, 33 (34.02%) were female, and 64 (65.9%) were male. Predominant populations were in the age group of 41 - 60; it was 60 out of 97 (61.8%), followed by 61-71 years (24.7%). Out of 97 fungal pathogens, Mucor, Aspergillus, and Mucor fungi were isolated predominantly; it was 32 (32.9%), 29 (29.8%), 16 (16.4%), and 11 (11.3%), respectively. Conclusions: Early Diagnosis and treatment will help manage SARS-CoV-2-associated fungal infections. The formulation of stringent infection control protocols, antimicrobial usage policy, and updated COVID-19 management guidelines by government authorities helps reduce infections.